GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » NP Life Sciences Health Industry Group Inc (OTCPK:NPLS) » Definitions » Equity-to-Asset

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Equity-to-Asset : 0.21 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is NP Life Sciences Health Industry Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. NP Life Sciences Health Industry Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $0.02 Mil. NP Life Sciences Health Industry Group's Total Assets for the quarter that ended in Dec. 2023 was $0.08 Mil. Therefore, NP Life Sciences Health Industry Group's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.21.

The historical rank and industry rank for NP Life Sciences Health Industry Group's Equity-to-Asset or its related term are showing as below:

NPLS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.15   Med: 0.87   Max: 1
Current: 0.21

During the past 6 years, the highest Equity to Asset Ratio of NP Life Sciences Health Industry Group was 1.00. The lowest was 0.15. And the median was 0.87.

NPLS's Equity-to-Asset is ranked worse than
85.45% of 268 companies
in the Education industry
Industry Median: 0.52 vs NPLS: 0.21

NP Life Sciences Health Industry Group Equity-to-Asset Historical Data

The historical data trend for NP Life Sciences Health Industry Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NP Life Sciences Health Industry Group Equity-to-Asset Chart

NP Life Sciences Health Industry Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.94 0.87 1.00 0.15 0.21

NP Life Sciences Health Industry Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.15 0.47 0.34 0.21

Competitive Comparison of NP Life Sciences Health Industry Group's Equity-to-Asset

For the Education & Training Services subindustry, NP Life Sciences Health Industry Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NP Life Sciences Health Industry Group's Equity-to-Asset Distribution in the Education Industry

For the Education industry and Consumer Defensive sector, NP Life Sciences Health Industry Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where NP Life Sciences Health Industry Group's Equity-to-Asset falls into.



NP Life Sciences Health Industry Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

NP Life Sciences Health Industry Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0.016/0.077
=0.21

NP Life Sciences Health Industry Group's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0.016/0.077
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NP Life Sciences Health Industry Group  (OTCPK:NPLS) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


NP Life Sciences Health Industry Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of NP Life Sciences Health Industry Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Business Description

Traded in Other Exchanges
N/A
Address
4125 Blackhawk Plaza Circle, Suite 166, Danville, CA, USA, 94506
NP Life Sciences Health Industry Group Inc offers international study tours, online and offline, in classical Chinese studies through classes, lectures, cultural, and artistic events. Its revenues are comprised of providing promotions and consulting services to its partner who gives international study tour services, commission to be received from partner enrollment services and mental health consulting services.
Executives
Guidong Wang director, 10 percent owner, officer: Chairman, CEO. Pres, Treas 4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Huaying Zhu director, officer: Secretary 4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Jonathan Ginsberg director 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Sanjun Kuang director, officer: CEO, President and Treasurer 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Meisang Hu director, 10 percent owner 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Huawei Li director, officer: Secretary 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Jianhua Wang 10 percent owner 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Headlines

No Headlines